Passive cocaine exposure, handling contaminated banknotes, touching surfaces in clubs or bathrooms, or being in a room where cocaine was used — can, in theory, transfer trace amounts to your skin, mouth or saliva, but it rarely produces a positive UK roadside drug test on its own.
4.6Top Rated Service 2026verified by TrustindexTrustindex verifies that the company has a review score above 4.5, based on reviews collected on Google over the past 12 months, qualifying it to receive the Top Rated Certificate.
High
Enter your details below for a free initial call.
The DrugWipe 5S device used by UK police is calibrated to a cut-off of around 20 nanograms of cocaine per millilitre of saliva, which is well above passive-exposure levels for the typical person. Where a positive screening result does occur, and the driver believes passive contact is the only plausible explanation, the station blood test almost always settles the question: passive trace concentrations sit far below the 10 microgram per litre benzoylecgonine limit set by the Drug Driving (Specified Limits) (England and Wales) Regulations 2014.
This guide explains how passive exposure works in real life, the published research on UK banknote contamination, why it rarely registers above the screening threshold, and the narrow circumstances where it can contribute to a successful defence. For the wider context, see the complete guide to cocaine and UK roadside drug testing, or speak to a cocaine drug driving solicitor.
Cocaine residue is more widespread in the UK environment than most people realise. The substance is sticky at the molecular level, transfers easily between surfaces, and persists on materials for weeks or months. In practical terms, three pathways account for most everyday passive exposure.
The first is currency. Cocaine residue on UK banknotes is well-documented in peer-reviewed forensic analysis going back to the early 2000s. Sample studies of notes in general circulation have found detectable cocaine in the substantial majority; figures in the literature commonly fall in the 70 to 90 per cent range, depending on region, sampling method, and detection sensitivity. Most of that residue is at very low levels, picograms or nanograms per note, but a smaller subset of notes carries higher concentrations, typically those that have been used in close contact with the drug itself. Handling cash routinely means handling trace cocaine routinely.
The second pathway is surfaces. Cocaine residue accumulates on hard surfaces in environments where the drug is used, bathroom counters in some night-time venues, cisterns, ATMs in certain locations, occasionally door handles or bannisters. The residue does not stay localised; it transfers to fingers, then to mouths via eating or face-touching. People who have spent time in environments where cocaine is used socially, without using it themselves, can carry trace residue on their hands and clothing for hours afterwards.
The third pathway is environmental. Cocaine vapour is not a significant source of exposure (unlike cannabis, where second-hand smoke exposure is a real phenomenon), but airborne particulate can be present where the drug has recently been prepared or used. Sleeping in a hotel room or rental property where cocaine has been used in the days beforehand, sharing a car with a regular user, or working in housekeeping or cleaning roles in venues where cocaine use is common, can all produce measurable trace exposure.
These pathways are real, but the residue levels involved are extremely low. The science question is whether trace contact concentrations are anywhere near the levels a UK roadside drug test is built to detect. The short answer is no, but the longer answer matters when defending a charge.
This is the question raised most often by drivers facing a charge they don’t understand. The honest answer involves a comparison of concentrations.
A heavily contaminated UK banknote can carry cocaine residue in the range of nanograms to low micrograms per note. Handling that note transfers a fraction of the residue to the fingers, perhaps one to ten per cent under typical conditions. If the person then touches their mouth, eats with their hands, or puts a finger near their lips, a further fraction reaches the oral cavity. By the time residue reaches saliva, the dilution into the salivary glands’ continuous output (roughly half a millilitre per minute in a resting adult) means the concentration in any sample taken by a roadside swab is typically well below the detection cut-off.
The DrugWipe 5S device used by most UK forces returns a positive cocaine result at approximately 20 nanograms of cocaine per millilitre of saliva. For context, that is a concentration consistent with recent active use, typically within the previous one to two days, depending on dose, frequency and individual metabolism. Passive trace exposure from currency or surface contact produces saliva concentrations one or two orders of magnitude below that threshold in nearly all documented cases. For the DrugWipe 5S threshold and the device’s overall sensitivity profile, the dedicated device page covers the details.
What can produce a borderline-positive screening result from passive contact is a combination of factors stacked together: handling multiple high-residue notes shortly before the test, eating immediately afterwards without washing hands, an unusually dry mouth at the time of testing (which reduces dilution), and the residue being transferred to the inner cheek surface that the swab samples. Even then, the resulting concentration usually sits at the lower edge of the device’s detection range, not deep into positive territory.
The Crown Prosecution Service and the device manufacturer both acknowledge that the cut-off is set deliberately above typical passive-exposure concentrations. The threshold exists precisely so that incidental contact with cocaine residue does not produce false-positive screening results in a population where banknote contamination is widespread.
Three properties of the UK testing regime combine to keep passive exposure out of the positive category in most real cases.
First is the cut-off itself. At approximately 20 ng/mL for cocaine on the DrugWipe 5S, the threshold sits above the saliva concentration produced by routine cash handling, surface contact, or social environmental exposure. The threshold is not arbitrary, it was set during device validation studies to distinguish recent active use from background trace contamination. Some other roadside drug screening devices use different chemistry, including the Dräger DrugTest 5000, which operates on similar but not identical thresholds. Either way, the calibration is built around the same principle.
Second is the two-stage process. Even if a roadside saliva swab does return positive, it is a screening result, not conclusive evidence. The driver is taken to the police station, and a blood test is administered, which is the analytical evidence on which the prosecution’s case is built. The UK legal limit is 10 micrograms per litre of benzoylecgonine in blood, the metabolite of cocaine, not the parent drug. Passive exposure does not produce meaningful benzoylecgonine levels in blood because the metabolite forms only when cocaine has entered the bloodstream and been processed by the liver and plasma esterases. Skin-to-mouth transfer produces some cocaine in saliva, but very little reaches systemic circulation, and very little of what reaches circulation is converted to benzoylecgonine. The station blood test and the 10μg/L limit is what determines whether a prosecution proceeds.
Third is the metabolite specificity. Because the legal limit is set on benzoylecgonine (not cocaine itself), the prosecution’s case depends on quantifying a substance that only forms inside the human body. Skin contact, oral surface contact, and even small amounts ingested without crossing into the bloodstream do not generate the metabolite at prosecutable concentrations. This is why passive-exposure cases that do produce a positive roadside swab very often result in no further action after the station blood test comes back below limit, or — where the case does proceed to charge, produce strong evidential challenges at the analysis stage. For the underlying saliva detection windows that explain how recent use registers and why trace contact usually does not, the dedicated saliva test guide covers the pharmacokinetics in detail.
Passive exposure rarely succeeds as a standalone defence, but it can contribute meaningfully to a wider defence strategy in specific circumstances.
The most useful application is in borderline blood test cases. Where the station blood test returns a benzoylecgonine reading close to the 10μg/L threshold, say between 8 and 15μg/L, the prosecution’s analytical certainty is at its weakest. The standard scientific uncertainty on a sample at that level can be a meaningful fraction of the reading. In that narrow band, evidence of plausible passive-exposure pathways combined with a credible account of no active use, no prior history of cocaine use, and a normal hair-test result (which can be commissioned independently) can shift the balance enough to produce either a withdrawn charge or an acquittal at trial. For the broader picture of how this fits with other defence routes, the accuracy challenges and false positives guide covers the analytical-challenge framework that often runs alongside.
A second application is where the route of exposure is unusually well-evidenced. A small number of UK cases have involved drivers who could prove specific environmental contamination, for example, occupational exposure documented by an employer’s records, or a documented case of drink-spiking where another individual added cocaine to the driver’s beverage without their knowledge. Where the evidential trail is genuinely strong, courts have shown willingness to consider passive exposure as a contributing factor to reasonable doubt, though rarely as the sole defence basis.
A third application is medical-prescription edge cases. Medical cocaine is still used as a topical anaesthetic in some UK ENT and dental procedures, and it produces measurable saliva concentrations for several hours afterwards. Where the driver had a documented medical procedure shortly before the test, the drug driving prescription medication framework provides the statutory route to a section 5A(3) “medical defence” rather than a passive-exposure defence, and that route, with proper documentation, is substantially more likely to succeed.
What rarely works on its own is a generic passive-exposure account without any of the above evidential support. Courts have heard the “I must have handled contaminated notes” argument many times and treat it sceptically without corroborating evidence. The argument carries weight when it is one strand in a multi-strand defence, not when it is asked to carry the whole case.
Drug driving in the UK is prosecuted under section 5A of the Road Traffic Act 1988, inserted by the Crime and Courts Act 2013. The structure of the offence matters for any innocent-contact argument.
Section 5A of the Road Traffic Act 1988 makes it an offence to drive, attempt to drive, or be in charge of a motor vehicle with a specified controlled drug in the body above a specified limit. The offence is strict liability in the sense that the prosecution does not have to prove impairment, only that the driver was over the limit. This is a critical legal point. Drink-driving prosecution under section 4 requires proof of impairment if the alcohol reading is below the limit; drug driving prosecution under section 5A does not. If the benzoylecgonine reading is above 10μg/L, the offence is made out regardless of whether the driver felt unaffected and regardless of whether they intended to consume cocaine.
This is why passive exposure is structurally difficult as a defence. The fact that the cocaine in your system came from an innocent source is not a defence to the substantive offence; the offence is “having the drug in your body above the limit”, not “having taken the drug deliberately”. The statute does include a statutory medical defence under section 5A(3), which protects drivers who took the drug as prescribed medication and were not advised against driving. But there is no equivalent statutory defence for passive or accidental exposure.
What the law does allow is a challenge to the prosecution’s evidence. If the blood reading is contested as inaccurate, contaminated, or unreliable, the prosecution’s case may fail on its evidential basis rather than on a substantive defence. Passive exposure usually enters at this evidential stage: not as “the drug got into my body innocently, so I should be acquitted” but as “the prosecution cannot prove I was over the limit given the alternative explanations for the reading”. The Drug Driving (Specified Limits) (England and Wales) Regulations 2014 set the analytical thresholds, and the case law on challenging those thresholds is where most passive-exposure arguments actually live.
A passive-exposure argument carries weight only when it is supported by evidence. The four documentary strands that strengthen the position most are: a hair test result showing no chronic cocaine use (commissioned through an accredited laboratory, typically over a 90-day window), a credible timeline of activity in the hours before the test (including any cash handling, time spent in environments where cocaine may have been present, and any medical procedures involving topical cocaine), independent analysis of the second blood sample retained at the police station (which the driver should always have accepted at custody), and witness statements from anyone present during the relevant period who can corroborate the account.
The hair test is particularly important because it provides an objective record of use pattern over months rather than days. A negative hair test for someone facing a positive roadside or blood reading is consistent with one-off passive exposure and inconsistent with regular concealed use. Where the prosecution’s case implies habitual use, a negative hair test is meaningful evidence.
The independent analysis of the second blood sample is the most evidentially powerful step. The sealed sample retained at the police station can be sent to an independent UKAS-accredited laboratory for re-analysis. Where the independent result diverges meaningfully from the police laboratory result, or where the independent analysis identifies issues with sample handling, calibration or contamination, the prosecution’s case is materially undermined. This step has time limits, so it must be initiated quickly after the charge.
Where these strands combine, and the case is genuinely a passive-exposure case rather than an undisclosed-use case, an experienced drug driving solicitor can run the defence persuasively. The right time to engage representation is before the first court date, and ideally before the second blood sample is sent for independent analysis. For tailored representation, our drug driving solicitors cover cocaine cases nationwide, with Shazia Ali leading the firm’s motoring offence practice.
Expert legal services in major cities, towns, and boroughs throughout England and Wales.
Understanding offences and process helps you make informed decisions about your future.
Can handling cocaine-contaminated cash cause me to fail a roadside drug test?
Handling contaminated banknotes can transfer trace cocaine residue to the fingers and from there to the mouth, but the resulting saliva concentration is almost always well below the 20 ng/mL detection threshold used by the UK police DrugWipe 5S device. The threshold is set deliberately above typical passive-exposure concentrations precisely because cocaine contamination of UK currency is widespread. A positive roadside test from cash handling alone is documented in case studies, but is rare.
What percentage of UK banknotes have trace cocaine on them?
Published forensic studies of UK banknotes in general circulation have found detectable cocaine residue on the substantial majority of notes sampled, with figures commonly reported in the 70 to 90 per cent range. The detection thresholds used in those studies are much lower than the roadside test thresholds — the studies detect picogram-level residues, while the roadside test requires nanogram-level concentrations in saliva. The two figures are not directly comparable: widespread trace contamination of notes does not translate into widespread positive roadside tests.
Can being in a room where cocaine was used affect my saliva test?
Sharing a confined space with active cocaine use can produce measurable trace exposure on skin, clothing and (rarely) in saliva, but the concentrations are typically well below the roadside screening threshold. The exposure is greatest where the user is preparing the drug (cutting lines on a surface releases more particulate than insufflation does) and where ventilation is poor. Documented cases of environmental exposure producing a positive UK roadside test are rare and usually involve prolonged exposure rather than brief contact.
Will the police accept passive exposure as a defence?
Police officers at the roadside do not assess defences; their role is to administer the screening test and make the arrest decision based on the result. The defence argument is raised later, either to the Crown Prosecution Service before charge or to the court at the first hearing. Passive exposure rarely succeeds as a standalone argument because UK drug driving is a strict liability offence: the prosecution does not have to prove how the drug entered the body. The argument carries weight only when combined with a borderline blood reading and supporting evidence.
Can someone spike my drink with cocaine and cause me to fail?
Yes, in principle. Drink-spiking with cocaine is documented in UK cases and can produce a positive screening and blood test result. Where the spiking can be evidenced through witness statements, venue records, hair test results showing no chronic use, and a credible timeline, it can form the basis of a defence. The argument is structurally similar to other passive-exposure defences in that section 5A does not include a statutory “involuntary intoxication” defence, but the evidential challenge to the prosecution’s case can succeed where the reading is borderline, and the corroborating evidence is strong.
How is passive exposure different from cross-reactivity?
Passive exposure means real cocaine entered the body through an innocent contamination pathway. Cross-reactivity means a non-cocaine substance triggered a positive reading on the screening device because the device chemistry could not distinguish it from cocaine. The two are different scientific phenomena with different defence implications. Cocaine has a relatively specific assay chemistry, so cross-reactivity and false positives are uncommon for cocaine specifically. Passive exposure, by contrast, involves genuine cocaine residue and depends on demonstrating the route of contact.
Does the blood test rule out passive exposure?
The station blood test is the strongest evidence against passive-exposure defences in most cases. Passive contact produces very little cocaine in the bloodstream, and even less benzoylecgonine — the metabolite the legal limit is set on. Where the blood test returns a benzoylecgonine reading well above the 10μg/L limit, passive exposure is rarely a credible explanation. Where the reading is close to the limit (typically 8 to 15μg/L), passive exposure becomes more plausible as part of a wider evidential challenge to the prosecution’s case.
Has anyone successfully used passive exposure as a defence in a UK case?
Passive exposure has contributed to successful defences in UK cases, though usually as one strand of a multi-strand argument rather than as the sole defence. Published case reports include drink-spiking cases where the spiking was evidenced through CCTV and witness statements, occupational exposure cases where employer records corroborated the exposure pathway, and borderline blood reading cases where independent analysis of the second sample produced a different result. Standalone passive-exposure arguments without corroborating evidence rarely succeed at trial because section 5A does not include a statutory defence for involuntary or accidental drug consumption.
I would like to thank Shazia and the Scarsdale team. Super efficient, fast responding and knew exactly what to do in the situation I was in. Highly recommend for any immigration needs
I would like to thank Shazia and the Scarsdale team. Super efficient, fast responding and knew exactly what to do in the situation I was in. Highly recommend for any immigration needs
Dynamic Program Designer